TNF and chronic obstructive pulmonary disease: After adjustment for age, sex, disease duration and severity, extraarticular RA, baseline steroid use, diabetes, chronic obstructive pulmonary disease, and smoking history, there was no significant difference in risk of infection between any of the anti-TNFα cohorts and the comparison cohort.